To develop a new strategy to overcome cisplatin resistance, we recently performed genome-wide screening for deubiquitinating enzymes (DUBs), and the results showed that DUBs promotes MAST1 protein stabilization by regulating its protein abundance in cisplatin-resistant cancer cells [21]. This evidence concerns the gene MAST1 and cancer.